{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-013851","form_type":"8-K/A","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2025-09-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.144444+00:00","generated_at":"2026-05-17T06:19:51.336778+00:00","sec_items":["9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"low","headline":"Protagenic Therapeutics updates auditor consent for Phytanix acquisition; no material news","bullets":["Company files Exhibit 23.1 with consent of GreenGrowth CPAs Inc.","Financial statements and pro forma data from prior filing remain unchanged.","Acquisition of Phytanix Bio was previously reported on May 19, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-013851","json":"https://secwatch.observer/filing/0001493152-25-013851.json","markdown":"https://secwatch.observer/filing/0001493152-25-013851.md","text":"https://secwatch.observer/filing/0001493152-25-013851.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000149315225013851/0001493152-25-013851-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000149315225013851/form8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:19:51.336778+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}